Literature DB >> 12113500

Prevalence of the genes for shigella enterotoxins 1 and 2 among clinical isolates of shigella in Israel.

M Yavzori1, D Cohen, N Orr.   

Abstract

Two enterotoxins, shigella enterotoxin 1 (SHET1) and shigella enterotoxin 2 (SHET2) have been recently characterized and are believed to play a role in the clinical manifestation of shigellosis. One hundred and twenty-one isolates of Shigella spp. of 13 different serotypes and variants and 10 isolates of enteroinvasive Escherichia coli (EIEC) isolated in Israel, were examined by polymerase chain reaction for the presence of SHET1 and SHET2 genes. SHET1 was only prevalent among isolates of S. flexneri 2a while SHET2 was found in all the serotypes that were tested except for several isolates of S. flexneri 1b that lost their virulence plasmid during storage. In addition, we found that the S. flexneri 2a vaccine strain T-32 Istrati contains the gene encoding for SHET1 but not that encoding for SHET2, suggesting that the latter is located within a large deletion occurring in the 140 Mda plasmid of this S. flexneri 2a non-invasive vaccine strain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113500      PMCID: PMC2869852          DOI: 10.1017/s0950268802006866

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

Review 1.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

2.  Epidemiology and genetic characterization of Shigella flexneri strains isolated from three paediatric populations in Egypt (2000-2004).

Authors:  S F Ahmed; M S Riddle; T F Wierzba; I Abdel Messih; M R Monteville; J W Sanders; J D Klena
Journal:  Epidemiol Infect       Date:  2006-05-11       Impact factor: 2.451

3.  A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1.

Authors:  Kwang-Il Jeong; Quanshun Zhang; John Nunnari; Saul Tzipori
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

Review 4.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release.

Authors:  Maria Fiorentino; Myron M Levine; Marcelo B Sztein; Alessio Fasano
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 6.  How Do the Virulence Factors of Shigella Work Together to Cause Disease?

Authors:  Emily Mattock; Ariel J Blocker
Journal:  Front Cell Infect Microbiol       Date:  2017-03-24       Impact factor: 5.293

7.  Comparative analysis of Shigella sonnei biotype g isolated from paediatric populations in Egypt, 1999-2005.

Authors:  J Dejli; R A Nada; A Mansour; A A El-Moniem; M O Wasfy; J D Klena
Journal:  Epidemiol Infect       Date:  2012-09-19       Impact factor: 4.434

8.  Occurrence of genes encoding enterotoxins in uropathogenic Escherichia coli isolates.

Authors:  Mahsa Mirzarazi; Seyedeh Elham Rezatofighi; Mahdi Pourmahdi; Mohamad Reza Mohajeri
Journal:  Braz J Microbiol       Date:  2015-03-01       Impact factor: 2.476

9.  Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China.

Authors:  Chuan-Ling Zhang; Qing-Zhong Liu; Juan Wang; Xu Chu; Li-Meng Shen; Yuan-Yu Guo
Journal:  BMC Infect Dis       Date:  2014-05-15       Impact factor: 3.090

10.  Longitudinal Characterization of Escherichia coli in Healthy Captive Non-Human Primates.

Authors:  Jonathan B Clayton; Jessica L Danzeisen; Ava M Trent; Tami Murphy; Timothy J Johnson
Journal:  Front Vet Sci       Date:  2014-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.